John Waller

The impact of myeloproliferative neoplasms (MPNs) on patient quality of life and productivity: results from the international MPN Landmark survey

Claire Harrison, Steffen Koschmieder, Lynda Foltz et al. · Annals of Hematology · 2017 · 144 citations · Full text

Medicine, Hematology, Internal Medicine +10

Treatment patterns and clinical outcomes among patients receiving palbociclib in combination with an aromatase inhibitor or fulvestrant for HR+/HER2-negative advanced/metastatic breast cancer in real-world settings in the US: Results from the IRIS study

Gavin Taylor‐Stokes, Debanjali Mitra, John Waller et al. · The Breast · 2018 · 78 citations

Medicine, Oncology, Pharmacology +17

Assessing physician and patient acceptance of infliximab biosimilars in rheumatoid arthritis, ankylosing spondyloarthritis and psoriatic arthritis across Germany

John Waller, E Sullivan, James Piercy et al. · Patient Preference and Adherence · 2017 · 64 citations · Full text

Medicine, Clinical Sciences, Internal Medicine +14

Real-World Treatment Patterns and Clinical Outcomes in Patients Receiving Palbociclib for Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Advanced or Metastatic Breast Cancer in Argentina: The IRIS Study

John Waller, Debanjali Mitra, Katie Mycock et al. · Journal of Global Oncology · 2019 · 53 citations · Full text

Medicine, Oncology, Pharmacology +17

Assessing gastroenterologist and patient acceptance of biosimilars in ulcerative colitis and Crohn's disease across Germany

E Sullivan, James Piercy, John Waller et al. · PLoS ONE · 2017 · 48 citations · Full text

Medicine, Clinical Sciences, Internal Medicine +13